New device aims to spot skin cancer earlier in High-Risk patients
NCT ID NCT04705168
Summary
This study tested a handheld device called Nevisense to see if it could help doctors better screen for melanoma in people with many unusual moles. The device measures tiny electrical signals in the skin, which may provide extra information beyond a standard visual exam. The goal is to improve early detection methods for those at higher risk of skin cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN LESION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
-
Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York, 10604, United States
Conditions
Explore the condition pages connected to this study.